ArticleMediators of inflammation2026
The Nonlinear Relationship Between the Aggregate Index of Systemic Inflammation and Serum Neurofilament Light Chain Levels in U.S. Adults: A Cross-Sectional Study.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of neurofilament light chain, CXCL9, IL-6, and TNFRSF11B with intrinsic capacity in community-dwelling older adults.GeroScience · 2026Article
- The Nonlinear Relationship Between the Aggregate Index of Systemic Inflammation and Serum Neurofilament Light Chain Levels in U.S. Adults: A Cross-Sectional Study.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundSystemic inflammation is linked to chronic diseases. This study examines the relationship between the aggregate index of systemic inflammation (AISI) and serum neurofilament light chain (sNfL), a marker of neuronal damage.
methodsData were obtained from the 2013-2014 National Health and Nutrition Examination Survey (NHANES). Participants with complete data on AISI and sNfL were included. Multiple linear regression and subgroup analyses were used to assess the association, and the nonlinear relationship was explored through smoothed curve fitting and threshold effect analyses.
resultsAmong 2,061 adults in NHANES 2013-2014, ln AISI was positively associated with sNfL (pg/mL) (fully adjusted β = 2.78 per 1-unit increase; 95% CI: 1.41-4.15; p < 0.0001). By quartiles of ln AISI, sNfL was higher in Q4 vs. Q1 (β = 6.22, 95% CI: 3.57-8.88; p < 0.0001), whereas Q2-Q3 were not significant after full adjustment; p for trend < 0.0001. Nonlinearity analysis identified an inflection at ln AISI = 4.34: below this value the estimate was negative and nonsignificant (β = -8.82; 95% CI: -18.10-0.46; p = 0.0627), whereas above it the association was positive and significant (β = 3.55; 95% CI: 2.05-5.04; p < 0.0001; likelihood ratio p = 0.013). Effect modification was observed by age (p for interaction = 0.0068), BMI (p for interaction = 0.0174), diabetes (p for interaction = 0.0004), hypertension (p for interaction = 0.0436), alcohol use (p for interaction = 0.0133), and stroke history (p for interaction = 0.0033).
conclusionIn the U.S. population, higher ln AISI values were independently associated with increased sNfL levels. A nonlinear relationship was observed between ln AISI and sNfL. This suggests that AISI may represent an important marker associated with sNfL levels beyond traditional clinical factors, and further studies are needed to better explore their association and potential underlying biological mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.